“PAIP2B gene as potential prognostic biomarker and miRNA regulator in pancreatic ductal adenocarcinoma”

https://pubmed.ncbi.nlm.nih.gov/38116489

This study suggests that PAIP2B, a gene with lower expression in pancreatic cancer patients, could serve as a potential prognostic biomarker and regulator of miRNA function in pancreatic ductal adenocarcinoma.